Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multivesicular radioimmunoliposomes with encapsulated actinium-225 for targeted alpha-particle therapy of intraperitoneal micrometastatic cancer
    Meeting Abstract

    Sofou, S.; Enmon, R.; McDevitt, M. R.; Jaggi, J.; Thomas, J. L.; Scheinberg, D. A.; Sgouros, G.
    Cancer Biotherapy and Radiopharmaceuticals (2004)

    Fulltext@MSK | Save
  • The role of Notch pathway in glial tumorigenesis
    Meeting Abstract

    Shih, A.; Holland, E.
    Neuro-Oncology (2004)

    Fulltext@MSK | Save
  • Generating human immune responses to mutations in bcr-abl kinase selected by imatinib
    Meeting Abstract

    Pinilla, J.; May, R.; Gomez, M.; Korontsvit, T.; Kappel, B.; Zakhaleva, V.; Dao, T.; Scheinberg, D. A.
    Blood (2004)

    Fulltext@MSK | Save
  • Sequential therapy with cytarabine and bismuth-213 (Bi-213)-labeled-HuM195 (anti-CD33) for acute myeloid leukemia (AML)
    Meeting Abstract

    Mulford, D. A.; Pandit-Taskar, N.; McDevitt, M. R.; Finn, R. D.; Weiss, M. A.; Apostolidis, C.; Morgenstern, A.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Bismuth-labeled anti-CD33 antibody for elimination of minimal residual disease in acute myeloid leukemia
    Meeting Abstract

    Mulford, D.; Divgi, C.; Mcdevitt, M.; Sgouros, G.; Finn, R.; Larson, S.; Apostolidis, C.; Morgenstern, A.; Scheinberg, D.; Jurcic, J.
    Cancer Biotherapy and Radiopharmaceuticals (2004)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide with or without rituximab has significant activity in patients with previously treated chronic lymphocytic leukemia and other low grade lymphoid neoplasms
    Meeting Abstract

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J.; Scheinberg, D. A.; Gencarelli, A. N.; Horgan, D.; Weiss, M. A.
    Blood (2004)

    Fulltext@MSK | Save
  • Clinical course and significance of the novel FLT3-Y842C mutation in a patient with AML treated with PKC412 monotherapy
    Meeting Abstract

    Kindler, T.; Breitenbuecher, F.; Kasper, S.; Estey, E.; Giles, F.; Feldman, E.; Ehninger, G.; Schiller, G.; Klimek, V.; Nimer, S. D.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Selective depletion of T cell clones responsible for GVHD in a murine model
    Meeting Abstract

    Kappel, B. J.; Eng, J. M.; Pinilla-Ibarz, J.; van den Brink, M. R. M.; Scheinberg, D. A.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Mechanisms of resistance to the FLT3-tyrosine kinase inhibitor PKC412 in patients with AML
    Meeting Abstract

    Heidel, F.; Breitenbuecher, F.; Kindler, T.; Solem, F. K.; Carius, B.; Thiede, H. M.; Cohen, P. S.; Roesel, J.; Estey, E. H.; Feldman, E.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone (AD-TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Zimman, R.; Hedvat, C. V.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2004)

    Fulltext@MSK | Save